ROVIDA, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.887
EU - Europa 3.988
AS - Asia 708
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 9.587
Nazione #
US - Stati Uniti d'America 4.854
PL - Polonia 2.126
IT - Italia 491
SE - Svezia 470
IE - Irlanda 461
HK - Hong Kong 227
CN - Cina 169
JO - Giordania 132
FI - Finlandia 84
GB - Regno Unito 82
VN - Vietnam 80
DE - Germania 79
UA - Ucraina 71
IN - India 41
CA - Canada 33
CH - Svizzera 29
RU - Federazione Russa 29
BE - Belgio 22
SG - Singapore 16
TW - Taiwan 14
TR - Turchia 11
FR - Francia 9
AT - Austria 8
MK - Macedonia 8
KR - Corea 6
ES - Italia 5
NL - Olanda 4
PH - Filippine 4
RO - Romania 3
AL - Albania 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EE - Estonia 1
HU - Ungheria 1
LY - Libia 1
MY - Malesia 1
RS - Serbia 1
Totale 9.587
Città #
Warsaw 2.126
Fairfield 754
Chandler 538
Dublin 456
Ashburn 386
Woodbridge 370
Seattle 328
Cambridge 290
Houston 265
Wilmington 243
Ann Arbor 205
Florence 193
Jacksonville 149
Hong Kong 134
Princeton 119
Lawrence 110
Altamura 104
Beijing 100
Boston 84
Dong Ket 72
Boardman 63
Buffalo 59
San Diego 55
Kent 44
Falls Church 39
Medford 39
Shanghai 38
Pune 33
Bern 28
Moscow 27
Brussels 22
Norwalk 21
Ottawa 18
Phoenix 17
Singapore 16
Milan 15
Redwood City 14
Toronto 14
Daan 12
Dearborn 12
London 12
Andover 11
Rome 10
Vienna 8
Hillsboro 7
Redmond 7
Izmir 6
Prato 6
West Jordan 6
Dallas 5
Laurel 5
Renton 5
Siena 5
Tappahannock 5
Barcelona 4
Cagliari 4
Cisano Bergamasco 4
Costa Mesa 4
Guangzhou 4
Los Angeles 4
Notre Dame 4
Castelliri 3
Detroit 3
Foggia 3
Fuzhou 3
Kilburn 3
Lynchburg 3
Menlo Park 3
Mumbai 3
New York 3
Ohrid 3
Turin 3
Anghiari 2
Augusta 2
Bologna 2
Bremen 2
Düsseldorf 2
Fremont 2
Garden Grove 2
Helsinki 2
Hounslow 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Kochi 2
Lappeenranta 2
Munich 2
Pavia 2
Poggio a Caiano 2
Prescot 2
Rho 2
Rubano 2
San Juan 2
San Mateo 2
Sesto Fiorentino 2
Silea 2
Southwark 2
Taiyuan 2
Trumbull 2
Acireale 1
Totale 7.826
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 267
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 255
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 246
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 233
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 233
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 232
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 224
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 223
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 219
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 218
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 216
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 215
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 205
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 198
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 180
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 161
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 146
Impact of ERK5 on the Hallmarks of Cancer 144
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 137
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 125
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 124
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 112
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 112
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 111
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 109
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 99
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 99
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 95
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 95
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 94
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 94
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 93
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 92
Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? 92
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 92
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 90
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 89
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 89
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 87
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 86
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 85
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 85
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 84
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 83
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 80
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 79
Tryptophan availability selectively limits NO-synthase induction in macrophages. 79
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 78
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 78
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 78
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 78
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 78
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 77
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 76
Fatty acids regulate the biology of cholangiocarcinoma cells 76
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 76
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 75
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 73
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 70
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 70
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 70
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 68
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 67
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 66
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 65
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 61
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 59
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 59
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 58
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 56
The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells 55
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 54
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 54
L’oncogene fes e la fosfotirosino-fosfatasi citosolica a basso peso molecolare interferiscono con la proliferazione e l’adesione cellulare 53
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 51
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 50
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 50
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 48
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 47
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 47
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 46
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 46
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 45
TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. 44
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 44
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 44
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 44
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 43
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 41
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 41
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 40
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 39
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 39
Effects of a human myeloid chronic leukemia cell line (K562) on in vivo angiogenesis 38
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 38
ERK5 inhibition elicits cellular senescence in human melanoma cells 38
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 37
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 34
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 33
Glucose Availability in Hypoxia Regulates the Selection of CML Progenitor Subsets with Different Resistance to Imatinib-Mesylate 32
Totale 9.533
Categoria #
all - tutte 26.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019512 0 0 0 0 0 0 0 0 0 0 279 233
2019/20202.179 146 180 77 155 251 242 224 286 205 155 210 48
2020/20211.475 133 155 50 157 69 164 77 109 143 205 83 130
2021/2022940 59 66 44 56 50 54 49 54 68 59 140 241
2022/20232.234 189 366 125 159 155 382 299 142 284 16 67 50
2023/2024840 30 84 122 35 58 114 54 200 25 39 79 0
Totale 9.792